Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000632972 | SCV000754181 | benign | Retinoblastoma | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002343228 | SCV002651390 | likely benign | Hereditary cancer-predisposing syndrome | 2019-10-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003411502 | SCV004115425 | uncertain significance | RB1-related disorder | 2023-01-20 | criteria provided, single submitter | clinical testing | The RB1 c.539C>T variant is predicted to result in the amino acid substitution p.Ser180Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0086% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/13-48921999-C-T). In ClinVar, this variant is classified as likely benign and benign (https://www.ncbi.nlm.nih.gov/clinvar/variation/527940/). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Ce |
RCV003392470 | SCV004133122 | likely benign | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | RB1: BP4 |
All of Us Research Program, |
RCV000632972 | SCV004844613 | likely benign | Retinoblastoma | 2023-10-02 | criteria provided, single submitter | clinical testing | |
Genetic Diagnostic Laboratory, |
RCV000632972 | SCV005046389 | likely benign | Retinoblastoma | 2024-05-20 | criteria provided, single submitter | clinical testing | Case and Pedigree Information: BILATERAL CASES:0, UNILATERAL CASES:1, TOTAL CASES:1, PEDIGREES:1. ACMG Codes Applied:BP4, BP6 |